Unknown

Dataset Information

0

Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases.


ABSTRACT: In mammals, a family of three inositol hexakisphosphate kinases (IP6Ks) synthesizes the inositol pyrophosphate 5-IP7 from IP6. Genetic deletion of Ip6k1 protects mice from high fat diet induced obesity, insulin resistance and fatty liver. IP6K1 generated 5-IP7 promotes insulin secretion from pancreatic ?-cells, whereas it reduces insulin signaling in metabolic tissues by inhibiting the protein kinase Akt. Thus, IP6K1 promotes high fat diet induced hyperinsulinemia and insulin resistance in mice while its deletion has the opposite effects. IP6K1 also promotes fat accumulation in the adipose tissue by inhibiting the protein kinase AMPK mediated energy expenditure. Genetic deletion of Ip6k3 protects mice from age induced fat accumulation and insulin resistance. Accordingly, the pan IP6K inhibitor TNP [N2-(m-trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates obesity, insulin resistance and fatty liver in diet induced obese mice by improving Akt and AMPK mediated insulin sensitivity and energy expenditure. TNP also protects mice from bone loss, myocardial infarction and ischemia reperfusion injury. Thus, the IP6K pathway is a potential target in obesity and other metabolic diseases. Here, we summarize the studies that established IP6Ks as a potential target in metabolic diseases. Further studies will reveal whether inhibition of this pathway has similar pleiotropic benefits on metabolic health of humans.

SUBMITTER: Mukherjee S 

PROVIDER: S-EPMC7144392 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases.

Mukherjee Sandip S   Haubner Jake J   Chakraborty Anutosh A  

Molecules (Basel, Switzerland) 20200319 6


In mammals, a family of three inositol hexakisphosphate kinases (IP6Ks) synthesizes the inositol pyrophosphate 5-IP7 from IP6. Genetic deletion of <i>Ip6k1</i> protects mice from high fat diet induced obesity, insulin resistance and fatty liver. IP6K1 generated 5-IP7 promotes insulin secretion from pancreatic β-cells, whereas it reduces insulin signaling in metabolic tissues by inhibiting the protein kinase Akt. Thus, IP6K1 promotes high fat diet induced hyperinsulinemia and insulin resistance i  ...[more]

Similar Datasets

| S-EPMC10466500 | biostudies-literature
| S-EPMC6383672 | biostudies-literature
| S-EPMC30134 | biostudies-literature
| S-EPMC4453010 | biostudies-literature
| S-EPMC4859692 | biostudies-literature
| S-EPMC7958180 | biostudies-literature
| S-EPMC3561551 | biostudies-literature
| S-EPMC5076471 | biostudies-literature
2022-02-22 | GSE126927 | GEO
| S-EPMC3887064 | biostudies-literature